These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6276835)

  • 21. [Prognostic significance of immunologic tests in cancer of the oral cavity].
    Szpirglas H; Castet-Sardjveladzé E; Piadé R; Roth-Ghanassia V; Tsamis J
    Rev Stomatol Chir Maxillofac; 1977; 78(3):207-18. PubMed ID: 329403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer active immunotherapy. Immunoprophylaxis and immunorestoration. An introduction.
    Mathé G
    Recent Results Cancer Res; 1976; 55():1-402. PubMed ID: 1087040
    [No Abstract]   [Full Text] [Related]  

  • 23. Concomitant immunopathology with squamous cell carcinomas of the head and neck regions.
    Berlinger NT; Good RA
    Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol; 1976; 82(5):588-94. PubMed ID: 138999
    [No Abstract]   [Full Text] [Related]  

  • 24. [An immuno-biological approach to the problem of the metastatic spread of cancers of the neck].
    Babighian G
    Rev Laryngol Otol Rhinol (Bord); 1974; 95(1-2):103-15. PubMed ID: 4421254
    [No Abstract]   [Full Text] [Related]  

  • 25. Head and neck tumor immunology.
    Carneiro CR
    Rev Paul Med; 1993; 111(4):6-7. PubMed ID: 8108652
    [No Abstract]   [Full Text] [Related]  

  • 26. Development of monoclonal antibodies with specificity to oral squamous cell carcinoma.
    Fantozzi RD
    Laryngoscope; 1991 Oct; 101(10):1076-80. PubMed ID: 1921634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An insight into cancer immunology and immunotherapy.
    Thompson RB
    Prog Clin Pathol; 1975; 6():159-76. PubMed ID: 1105670
    [No Abstract]   [Full Text] [Related]  

  • 28. Evidence for the changes of antitumor immune response during lymph node metastasis in head and neck squamous cell carcinoma.
    Kumagai K; Hamada Y; Gotoh A; Kobayashi H; Kawaguchi K; Horie A; Yamada H; Suzuki S; Suzuki R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Sep; 110(3):341-50. PubMed ID: 20598595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunobiologic aspects of head and neck cancer. Clinical and laboratory correlates.
    Vlock DR
    Hematol Oncol Clin North Am; 1991 Aug; 5(4):797-820. PubMed ID: 1716250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the immune system in head and neck cancer.
    de Castro G; Isaacsson Velho PH
    Curr Opin Oncol; 2015 May; 27(3):157-8. PubMed ID: 25850579
    [No Abstract]   [Full Text] [Related]  

  • 31. Cell-mediated immunity to herpes simplex virus types 1 and 2 antigens in leukoplakia and carcinoma in man.
    Shillitoe EJ; Tarro G; Lehner T
    Oncology; 1976; 33(4):192-5. PubMed ID: 65753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell mediated immunity to herpesvirus type 1 in carcinoma and pre-cancerous lesions.
    Lehner T; Shillitoe EJ; Wilton JM; Ivanyi L
    Br J Cancer Suppl; 1973 Aug; 1():128-34. PubMed ID: 4374226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letter: Alternate explanation for trichinosis associated with oral carcinoma.
    Segelman AE
    J Oral Surg; 1975 May; 33(5):328. PubMed ID: 1055186
    [No Abstract]   [Full Text] [Related]  

  • 34. Epstein-Barr virus (EBV)-induced transformation of human lymphoid cells and immunosurveillance against lymphoma development.
    Klein G
    Ann Immunol (Paris); 1973 Aug; 124(3):391-405. PubMed ID: 4359277
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunotherapy for head and neck cancer.
    Wu AA; Niparko KJ; Pai SI
    J Biomed Sci; 2008 May; 15(3):275-89. PubMed ID: 18392689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral complications of experimental plasma exchange in head and neck cancer.
    Jackson MJ; Seder RH; Katz AE
    J Prosthet Dent; 1986 Jun; 55(6):718-22. PubMed ID: 3522867
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies of the nature of herpesvirus-induced tumour-associated antigens induced by herpes simplex virus type 1 and further analysis of their relationship with squamous-cell carcinomas of the head and neck region.
    Hollinshead AC; Chretien PB; Tarpley JL
    IARC Sci Publ (1971); 1975; (11 Pt 2):307-11. PubMed ID: 191376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on immunology of head and neck cancer.
    Katz AE
    Med Clin North Am; 1993 May; 77(3):625-31. PubMed ID: 8492614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telltale tumor infiltrating lymphocytes (TIL) in oral, head & neck cancer.
    Lei Y; Xie Y; Tan YS; Prince ME; Moyer JS; Nör J; Wolf GT
    Oral Oncol; 2016 Oct; 61():159-65. PubMed ID: 27553942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adult rhabdomyoma. A light microscopic, ultrastructural, virologic, and immunologic analysis.
    Cleveland DB; Chen SY; Allen CM; Ahing SI; Svirsky JA
    Oral Surg Oral Med Oral Pathol; 1994 Feb; 77(2):147-53. PubMed ID: 8139832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.